Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Your evaluation may include the performance of specific blood tests, including (but not limited to) cell counts, measurement of various blood chemistries and markers of inflammation. We can measure many things in your blood such as salts, blood cell counts and protein markers specific to the heart (one is called BNP). Additional tests may include blood chemistries, evaluation of liver and kidney functions, and genetic studies). In some cases, genetic testing may be recommended. In addition, we may ask you to join our ongoing studies by allowing us to collect and store some of your blood for future analysis.
Blood tests help your doctor check your immunoglobulin (antibody) levels. These are the proteins made by plasma cells. Multiple myeloma causes an increase in M protein (immunoglobulin) levels. Your doctor will also take a small sample of your blood for a complete blood count (CBC) and a comprehensive metabolic panel. This will let your doctor check for anemia, hypercalcemia, kidney injury and other problems that may result from multiple myeloma.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.